Latest / The Diagnostics & Lab Testing Business Brief
The Diagnostics & Lab Testing Business Brief — Friday, October 30, 2026
The Diagnostics & Lab Testing Business Brief — Friday, October 30, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
DEVICE — Dexcom Q3 2026 results: reported Oct 29, 2026 — worldwide revenue $1.344 billion (+11% year over year; U.S. +14%, international +5%); GAAP operating income $327.2 million (24.3% of revenue); non-GAAP gross margin 65.1%; full-year 2026 revenue guidance raised at the midpoint to $5.20–$5.25 billion, with non-GAAP operating margin guidance increased to ~24% and a new share repurchase authorization of up to $1.0 billion; strategic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.